Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder which starts in childhood and is characterized by symptoms of attention deficit, hyperactivity and impulsivity. Persistence into adolescence is frequently associated with among other low educational achievement, interpersonal difficulties, anxious and depressive symptoms and sleep problems. Treatment guidelines recommend psychological treatment as part of the treatment plan, however compared to children and adults, there is still a substantial lack of knowledge about appropriate psychological treatment in adolescents. The present study examines a psychological intervention for adolescents with ADHD, cognitive behavior group therapy. The intervention consists of 12 weekly cognitive behavioral therapy sessions addressing core difficulties and concerns of the adolescent population with ADHD. The investigators wish to determine the efficacy of group therapy in adolescents with ADHD who receive medical treatment but still have impairing ADHD symptoms.
Change February 1st 2017: Inclusion of patients with mild to moderate behavioral problems in order to achieve enough participants in the study. Change February 1st 2017: The study primarily recruits patients who are on pharmacological treatment for ADHD. However, for ethical reasons and in order to achieve enough participants, the study will also recruit patients who have not responded to at least two drug trials or have been unable to continue pharmacological treatment because of intolerable side effects. Change February 1st 2018: The Weiss Functional Impairment Rating Scale, Rosenberg and BRIEF questionnaires will not be collected at the 9-month follow-up due to lack of resources (project assistance).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
100
1,5 hours weekly session during 12 weeks, 8 participants, 2 therapists.
Education on ADHD, and ADHD medication if indicated
Barne- og ungdomspsykiatrisk poliklinikk, St Olavs Hospital
Trondheim, Norway
ADHD-Rating Scale (ADHD-RS)
interview
Time frame: 12 weeks (at baseline and immediately after the last group therapy session)
ADHD-Rating Scale (ADHD-RS)
Time frame: 9 months
Clinical Global Impression (CGI)
Time frame: 12 weeks (at baseline and immediately after the last group therapy session)
Weiss Functional Impairment Rating Scale (WFIRS)
Time frame: 12 weeks (at baseline and immediately after the last group therapy session)
Weiss Functional Impairment Rating Scale (WFIRS)
Time frame: 9 months
Children's Global Assessment Scale (CGAS)
Time frame: 9 months
Anxiety symptoms (SCARED)
Time frame: 12 weeks (at baseline and immediately after the last group therapy session)
Depressive symptoms (Mood and Feelings Questionnaire (MFQ) Norwegian version "Humøret ditt")
Time frame: 12 weeks (at baseline and immediately after the last group therapy session)
Sleep problems (Adolescent Sleep Wake Scale
Time frame: 12 weeks (at baseline and immediately after the last group therapy session)
Self-esteem (Rosenberg Self-Esteem Scale)
Time frame: 12 weeks (at baseline and immediately after the last group therapy session)
Self-esteem (Rosenberg Self-Esteem Scale)
Time frame: 9 months
Self-efficacy (General Perceived Self-Efficacy Scale)
Time frame: 12 weeks (at baseline and immediately after the last group therapy session)
Self-efficacy (General Perceived Self-Efficacy Scale)
Time frame: 9 months
Executive functioning (Behavior Rating Scale of Executive Functioning, BRIEF)
Time frame: 12 weeks (at baseline and immediately after the last group therapy session)
Executive functioning (Behavior Rating Scale of Executive Functioning, BRIEF)
Time frame: 9 months
ASEBA Brief Problem Monitor
Time frame: 9 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.